Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent
1991-11-29
1999-08-03
Feisee, Lila
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
53038822, 53038875, 530402, 5303873, 435 697, 435 7021, C12P 2104, C12P 2108, C07K 1113, C07K 1628
Patent
active
059324481
ABSTRACT:
Methods for producing and using bispecific antibodies formed by leucine zippers are provided. Leucine zippers capable of preferentially forming heterodimers are respectively linked to epitope binding components comprising different binding specificities. Bispecific antibodies are formed by pairwise association of the leucine zippers, forming a heterodimer which links the two distinct epitope binding components. Heterodimerization can occur by interaction of the two leucine zipper regions, forming a bispecific antibody. Such a bispecific antibody may be further stabilized by the formation of intermolecular chemical bonds, such as disulfide bonds, between the two monomeric subunits. Subsequent to the formation of such intermolecular bonds between the monomeric subunits, the leucine zippers may be removed or retained. Bispecific antibodies produced by these methods are substantially pure and may be produced in high yields and on a large scale. Alternatively, bifunctional heterodimers may be formed by linking an epitope binding component to a macromolecular species that is not an epitope binding component.
REFERENCES:
patent: 5582996 (1996-12-01), Curtis
Abel and Maniatis, Nature 341:24-25 (1989).
Bator and Reading, in Therapeutic Monoclonal Antibodies, Borrebaech and Larrick, eds., Stockton Press, p. 35 (1990).
Better et al., Science 240:1041-1943 (1988).
Brennan et al., Science 229:81-83 (1985).
Gilliland et al., Proc. Natl. Acad. Sci. USA 85:7719-7723 (1988).
Blondel and Bedouelle, Protein Engineering 4:457-461 (1991).
Curran and Franza, Cell 55:395-397 (1988).
Glennie et al., J. Immunol. 139:2367-2375 (1987).
Landschulz et al., Science 240:1759-1764 (1988).
Lanzavecchia and Scheidegger, Eur. J. Immunol. 17:105-111 (1987).
McKnight, Scientific American, pp. 54-64, Apr. 1991.
Milstein and Cuello, Immunol. Today 5:299-304 (1984).
Neuberger et al., Nature 312:604-608 (1984).
O'Shea et al., Science 254:539-554 (1991).
O'Shea et al., Science 245:646-648 (1989).
Parham, J. Immunol. 131:2895-2902 (1983).
Queen et al., Proc. Natl. Acad. Sci. USA 86:10029-1033 (1989).
Shin and Morrison, Proc. Natl. Acad. Sci. USA 87:5322-5326 (1990).
Staerz and Bevan, Immunology Today 7:241-245 (1986).
Uchiyama et al., J. Immunol. 126:1393-1397 (1981).
Schuermann et. al. Feb. 1991 Nucleic Acids Research. vol. 19. No. 4, 739.
Cole Michael S.
Kostelny Sheri A.
Tso J. Yun
Bansal Geetha
Feisee Lila
Protein Design Labs., Inc.
LandOfFree
Bispecific antibody heterodimers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bispecific antibody heterodimers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bispecific antibody heterodimers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-848830